Australian regulator TGA warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic

7 hours ago

TGA says product information for some diabetes and weight loss drugs updated with warning of NAION disorder

Australia’s medicines regulator has issued warnings for several type 2 diabetes and obesity-related treatments – including Ozempic and Mounjaro – over the potential to cause a “rare but severe” eye disorder that could lead to blindness.

The Therapeutic Goods Administration’s (TGA) warning came after several GLP-1 RA medicines, marketed in Australia as Ozempic, Wegovy and Mounjaro among other products, have been linked to 36 cases of the condition.

Continue reading...
Click here to Read More
Previous Article
Sun, football and Burnham push UK consumer confidence and retail sales higher
Next Article
Short breaks set the tone for Greek travellers, new data reveals

Related World Updates:

Are you sure? You want to delete this comment..! Remove Cancel

Comments (0)

    Leave a comment